Abstract :
Although the clinical safety of compounds targeting the core components of the Wnt signaling pathway remains to be determined, a simple in vivo chemical screen identifies small molecules that inhibit Wnt signaling in a cell type-specific manner (Ni et al., this issue of Chemistry & Biology).
